Antibiotic Selection for Soft Tissue Infections

Introduction to Soft Tissue Infections

The Infectious Diseases Society of America recommends using an oral agent targeting streptococci, such as cephalexin 500 mg every 6 hours or penicillin VK 250-500 mg every 6 hours, for uncomplicated cellulitis without systemic signs 1
For severe infections with systemic toxicity or suspected MRSA, the Infectious Diseases Society of America suggests initiating vancomycin 15 mg/kg IV every 12 hours plus piperacillin-tazobactam 3.375-4.5 g IV every 6-8 hours 1

For simple cellulitis without purulence or systemic signs, the Infectious Diseases Society of America recommends first-line oral options, including cephalexin 500 mg every 6 hours, penicillin VK 250-500 mg every 6 hours, or dicloxacillin, targeting streptococci and methicillin-sensitive S. aureus 2
The duration of treatment for uncomplicated cellulitis should be at least 5 days, extending if no improvement is seen 2
For penicillin-allergic patients, the Infectious Diseases Society of America suggests clindamycin 300-450 mg four times daily 2

For cellulitis with systemic signs but no MRSA risk factors, the Infectious Diseases Society of America recommends IV options, including cefazolin 1 g every 8 hours IV or nafcillin/oxacillin 2 g every 6 hours IV 1, 3
The Infectious Diseases Society of America suggests transitioning to oral cephalexin 500 mg every 6 hours once clinically improved 2
For cellulitis with MRSA risk factors, the Infectious Diseases Society of America recommends vancomycin 15 mg/kg IV every 12 hours as the empiric choice 1, 2

For necrotizing fasciitis or suspected polymicrobial infection, the Infectious Diseases Society of America recommends an empiric broad-spectrum regimen, including vancomycin 15 mg/kg IV every 12 hours plus piperacillin-tazobactam 3.375 g every 6 hours or 4.5 g every 8 hours IV 1, 3
Urgent surgical debridement is mandatory and takes priority over antibiotics 1, 4
For documented Group A streptococcal necrotizing fasciitis, the Infectious Diseases Society of America recommends penicillin 2-4 million units IV every 4-6 hours plus clindamycin 600-900 mg IV every 6-8 hours 1, 3, 4

For pyomyositis, the Infectious Diseases Society of America recommends empiric vancomycin 15 mg/kg IV every 12 hours, with the addition of gram-negative coverage if immunocompromised or open trauma 1, 3
For diabetic foot infections, the Infectious Diseases Society of America suggests mild cases be treated similarly to uncomplicated cellulitis, while moderate-severe cases require broad-spectrum coverage, considering MRSA coverage with vancomycin if risk factors are present 5
For animal/human bites, the Infectious Diseases Society of America recommends amoxicillin-clavulanate 875/125 mg twice daily orally for outpatient treatment, providing coverage for Pasteurella, anaerobes, and oral flora 5

The Infectious Diseases Society of America recommends a treatment duration of at least 5 days for uncomplicated cellulitis, extending if not improving, and until resolution for purulent infections, typically 7-10 days 2
For necrotizing infections, treatment should continue until no further debridement is needed and the patient is afebrile for 48-72 hours 4
The Infectious Diseases Society of America suggests transitioning to oral therapy when clinically improved, afebrile, able to tolerate oral intake, and no ongoing bacteremia, ensuring adequate oral bioavailability 1, 2, 3